Raras
Buscar doenças, sintomas, genes...
Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome de deficiência intelectual grave-diplegia espástica progressiva é uma doença genética rara e nova caracterizada por deficiência intelectual grave, ataxia, dismorfismos craniofaciais e espasticidade muscular. É um tipo de deficiência intelectual sindrômica autossômica dominante.

🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PE, CE, DF, SP +5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
8 sintomas
🧠
Neurológico
7 sintomas
📏
Crescimento
4 sintomas
🦴
Ossos e articulações
4 sintomas
👁️
Olhos
2 sintomas
👂
Ouvidos
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

Atraso de crescimento
Fusão vertebral C2/C3 cervical
Filtro curto
Hiperintensidade da substância branca cerebral na ressonância magnética
Pé torto equinovaro
Deficiência intelectual
35sintomas
Sem dados (35)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 35 características clínicas mais associadas, ordenadas por frequência.

Atraso de crescimentoGrowth delay
Fusão vertebral C2/C3 cervicalCervical C2/C3 vertebral fusion
Filtro curtoShort philtrum
Hiperintensidade da substância branca cerebral na ressonância magnéticaHyperintensity of cerebral white matter on MRI
Pé torto equinovaroTalipes equinovarus

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa3
Últimos 10 anos200publicações
Pico2025103 papers
Linha do tempo
2023Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Autosomal dominant
BRPF1PeregrinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, which have a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:24065767, PubMed:27939640). Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac) (PubMed:24065767). Some HAT complexes preferentially mediate histone H3 'Lys-23' (H3K23ac) acetylation (PubMed:27939640). Positively regulates the transcription of RU

LOCALIZAÇÃO

NucleusChromosomeCytoplasm

VIAS BIOLÓGICAS (2)
Regulation of TP53 Activity through AcetylationHATs acetylate histones
MECANISMO DE DOENÇA

Intellectual developmental disorder with dysmorphic facies and ptosis

An autosomal dominant neurodevelopmental disorder characterized by delayed psychomotor development, intellectual disability, delayed language, and facial dysmorphisms, most notably ptosis. Additional features may include poor growth, hypotonia, and seizures.

OUTRAS DOENÇAS (2)
intellectual developmental disorder with dysmorphic facies and ptosis3p25.3 microdeletion syndrome
HGNC:14255UniProt:P55201

Variantes genéticas (ClinVar)

263 variantes patogênicas registradas no ClinVar.

🧬 BRPF1: NM_001003694.2(BRPF1):c.351T>A (p.Asp117Glu) ()
🧬 BRPF1: NM_001003694.2(BRPF1):c.419A>C (p.Glu140Ala) ()
🧬 BRPF1: NM_001003694.2(BRPF1):c.1044G>A (p.Trp348Ter) ()
🧬 BRPF1: GRCh37/hg19 3p26.3-14.3(chr3:2263690-55016039)x3 ()
🧬 BRPF1: NM_001003694.2(BRPF1):c.2436_2437insAA (p.Arg813fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome

Centros de Referência SUS

13 centros habilitados pelo SUS para Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome

Centros para Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 16

Biallelic DIAPH1 pathogenic variants cause a neurodevelopmental syndrome occasionally associated with immunodeficiency. This study aims to define the clinical and immunological spectrum of DIAPH1-related neuroimmunological syndrome and explore the gene's developmental role using vertebrate models. 53 individuals with biallelic DIAPH1 variants, including 33 previously unreported patients were studied. Clinical features were analysed and functional studies were conducted using knockout models in Danio rerio and Xenopus tropicalis. Clinical features included developmental delay, intellectual disability, progressive microcephaly, cortical visual impairment or blindness, epilepsy, and frequent occipital-predominant brain abnormalities. Almost half suffered from infections, mainly affecting their respiratory tract related to epilepsy and aspiration. Although the majority had normal lymphocyte subsets and serum immunoglobulins, T-cell receptor excision circles and naïve T-lymphocyte counts were consistently low. The Xenopus model mirrored growth and eye defects seen in humans, while zebrafish exhibited no overt malformations but showed seizure-like behaviour in Phenothiazine assays. DIAPH1 is critical for neurodevelopment, immune regulation, and DNA repair. The DNA repair defect may influence susceptibility to infection, lymphoma, or treatment-related toxicity. Although absolute T-cell numbers are not consistent with SCID, impaired T-cell maturation suggests these patients could be identified by TREC newborn screening before neurological symptoms develop. WAGR spectrum disorder was initially named for its classic features of Wilms tumor (WT), aniridia, genitourinary anomalies, and a range of neurodevelopmental delays. However, in recent years the phenotypic spectrum has expanded to include additional common findings (such as neurobehavioral/psychiatric issues, obesity, respiratory and gastrointestinal issues, hypotonia and scoliosis, and recurrent infections). The diagnosis of WAGR spectrum disorder is established in a proband with suggestive findings and a deletion of chromosome 11p13 that includes the genes WT1 and PAX6 identified by molecular genetic testing. Treatment of manifestations: Multidisciplinary care by pediatric specialists in oncology (Wilms tumor risk assessment and management), ophthalmology (complications of aniridia), early childhood development (developmental delay / intellectual disability, neurobehavioral issues), urology (genital anomalies and congenital anomalies of the kidney and urinary tract), and nephrology (kidney function), as well as other specialists to manage less common findings (e.g., obesity, respiratory issues, gastrointestinal involvement, and recurrent infections). Surveillance: Recommendations have been published regarding routinely scheduled follow up to monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations. WAGR spectrum disorder is an autosomal dominant disorder typically caused by a de novo 11p13 deletion. Rarely, an unaffected parent of a proband with WAGR spectrum disorder has a predisposing chromosome rearrangement. Recommended evaluations of the parents to confirm their genetic status and to allow reliable recurrence risk counseling include genomic testing (to detect the 11p13 deletion present in the proband) and chromosome testing (to detect a predisposing chromosome rearrangement). If neither parent has the 11p13 deletion identified in the proband or a predisposing chromosome rearrangement, and if parental identity testing has confirmed biological maternity and paternity, the two possibilities to be considered are the proband has a de novo deletion or the proband inherited the deletion from a parent with gonadal (or somatic and gonadal) mosaicism. Note: Testing of parental leukocyte DNA may not detect all instances of somatic mosaicism and will not detect a deletion that is present in the germ (gonadal) cells only.

#2

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology2026

CTNNB1 monoallelic pathogenic variants account for up to 4% of genetically determined cerebral palsy cases, yet their phenotypic spectrum remains poorly defined. We retrospectively analyzed 25 individuals with pathogenic CTNNB1 variants using medical records and a questionnaire. Data included genetic variants, perinatal history, developmental milestones, behavioral characteristics, head growth, feeding, sleep difficulties, neurological and ophthalmological assessments. Brain MRIs were reviewed by expert neuroradiologists. Twenty-two distinct heterozygous variants were identified. Microcephaly occurred in 16/22 patients. All exhibited global developmental delay, independent walking was achieved at a mean age of 2.1 years, with regression in 4/16 independent walkers. Behavioral disorders were frequent, as were oral sensorimotor disorders (21/25) and sleep disturbances (13/21). Lower limb hypertonia was present in 22/25 patients [spastic (8) and/or dystonic (11)]. Unstable gait were common among ambulatory patients. Exaggerated startle reactions, often since birth, were reported in 16/21. Exudative vitreoretinopathy was identified in 3/5 patients with retinal angiography. Brain MRI (19 patients) showed: thickening of anterior commissure (8), frontal lobe hypoplasia (9), widening of superior vermian sulci (10) and corpus callosum anomalies (7). This study broadens the spectrum of CTNNB1-related syndrome, reporting a complex motor phenotype combining (i) gait disturbances related to dystonic or non-dystonic hypertonia and unsteadiness, sometimes associated to dystonia in other body parts (ii) possible deterioration of motor achievements over the course of the disease (iii) an exaggerated startle reflex. New non-specific brain anomalies are precisely described. Our work underscores the need for registries and longitudinal studies to refine characterization and guide future therapies.

#3

International Clinical Evidence-based Guideline for Kleefstra Syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Jan 20

Kleefstra syndrome (KLEFS1) is a rare monogenic neurodevelopmental disorder (mNDD) with multisystem involvement, caused by disruption of EHMT1 function, resulting in significant burden on affected individuals and their families. The current shortage of and globally scattered syndrome-specific knowledge has led to significant disparities in the access to and provision of evidence-based and individual-centered expert care. To address the challenges and improve outcomes for individuals with KLEFS1, an international KLEFS1 guideline consortium was formed consisting of 43 participants, both clinical experts and patient-representatives, from 15 different countries. The primary goal of the consortium was to develop a comprehensive and high-quality guideline for KLEFS1, aiming to enhance patient care, establish a uniform minimum international standard of care, and support decision-making. The current clinical guideline is evidence-based and includes 66 tailored recommendations to improve KLEFS1 care. The comprehensive methodological approach ensures broad consensus and supports effective implementation. Furthermore, this guideline serves as a valuable methodological model for guideline development in the context of rare disorders. PPP1R21-related El-Hattab-Schmidts syndrome is predominantly a neurodevelopmental disorder characterized by global developmental delay, intellectual disability, hypotonia, and coarse facial features (highly arched and thick eyebrows, thick vermilion of the upper and lower lips, broad nasal bridge, and low-set ears). Ophthalmologic manifestations (strabismus, nystagmus, and optic atrophy) are common. Respiratory issues can include apnea, recurrent respiratory infections, and laryngomalacia. Cardiac manifestations (left ventricular hypertrophy or noncompaction, hypertrophic cardiomyopathy, and atrial septal defects), neurobehavioral features, seizures, and hepatomegaly have been reported. The diagnosis of PPP1R21-related El-Hattab-Schmidts syndrome is established in a proband by identification of biallelic pathogenic variants in PPP1R21 by molecular genetic testing. Treatment of manifestations: Developmental and educational services; feeding therapy; gastrostomy tube placement as needed for persistent feeding issues; treatment of refractive errors and strabismus per ophthalmologist; low vision services as needed; management of apnea and recurrent respiratory infections per pulmonologist; treatment of cardiac manifestations per cardiologist; standard treatment for epilepsy; transitional care planning; social work and family support. Surveillance: At each visit assess developmental progress, educational needs, mobility, self-help skills, growth parameters, nutritional status, safety of oral intake, and evidence of aspiration or respiratory insufficiency. Eye exam with frequency per treating ophthalmologist; respiratory examination with oxygen saturation at each visit; chest radiographs as indicated; echocardiogram annually; behavioral assessment at each visit; assessment of seizures at each visit; assessment of family and social work needs at each visit. PPP1R21-related El-Hattab-Schmidts syndrome is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a PPP1R21 pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the PPP1R21 pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing are possible.

#4

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology2026 Mar

COL18A1 encodes the α1 chain of collagen type XVIII, a nonfibrillar collagen expressed in vascular and epithelial basement membranes. Biallelic pathogenic variants in COL18A1 have been associated with Knobloch syndrome, a condition defined by ophthalmologic abnormalities, though patients often have some or all of brain malformations, epilepsy, and intellectual disability. We reviewed our research and clinical databases for patients with seizures and biallelic COL18A1 variants suspected to be pathogenic. Three patients were identified, all of whom had epilepsy and global development impairment, with two having had developmental regression and drug-resistant seizures. None of the patients had severe ophthalmologic disease. All three patients had one heterozygous likely pathogenic frameshift COL18A1 variant on one allele, with the other allele carrying a rare heterozygous missense COL18A1 variant of less certain pathogenicity. These data raise the possibility that COL18A1 disruption could produce phenotypes without severe eye abnormalities but significant neurologic dysfunction.

#5

De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.

American journal of human genetics2026 Jan 08

Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo variants in KDM2A, a lysine demethylase crucial for embryonic development, in 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe intellectual disability. Other core symptoms included feeding difficulties; growth issues, such as intrauterine growth restriction, short stature, and microcephaly; and recurrent facial features, such as epicanthic folds, upslanted palpebral fissures, thin vermillion of the lips, and low-set ears. Expression of human disease-causing KDM2A variants in a Drosophila melanogaster model led to neural degeneration, motor defects, and reduced lifespan. Interestingly, pathogenic variants in KDM2A affected physiological attributes, including subcellular distribution, expression, and stability in human cells. Genetic epistasis experiments indicated that KDM2A variants act via a dual mechanism-loss of nuclear function for some variants tested and additional cytoplasmic gain-of-function toxicity for c.704C>T (p.Pro235Leu), as eliminating endogenous Drosophila Kdm2 did not produce noticeable neurodevelopmental phenotypes. Data from enzymatic-methylation sequencing support the suggested gene-disease association by showing aberrant methylome profiles in affected individuals' peripheral blood. Combining our genetic, phenotypic, and functional findings, we establish de novo variants in KDM2A as causative for a syndromic neurodevelopmental disorder.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 196

2026

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology
2026

Dual rare genetic variants: case report of a child with SBIDDS syndrome and citrullinemia type 1.

Italian journal of pediatrics
2026

Fenfluramine in SCN1A-related GEFS+: A multicenter observational study on efficacy, EEG improvement, and tolerability.

Epilepsia open
2026

First demyelinating attack in children: A twelve year single center cohort.

Multiple sclerosis and related disorders
2026

Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.

Epilepsia
2026

International Clinical Evidence-based Guideline for Kleefstra Syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology
2026

Proceedings of the 12th International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01.

American journal of ophthalmology case reports
2026

Case report and literature review of neurodevelopmental syndrome linked to DOT1L variants.

Gene
2026

De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.

American journal of human genetics
2025

An Atypical Female Case of Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome with Severe Lower Limb Contractures Requiring Orthopedic Surgery.

Clinical, cosmetic and investigational dermatology
2026

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management.

International ophthalmology clinics
2025

Pathogenic variants in the cohesin loader subunit MAU2 lead to a new Cornelia de Lange Syndrome subtype.

medRxiv : the preprint server for health sciences
2026

Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.

Neurobiology of disease
2025

Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.

Frontiers in genetics
2026

Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.

Balkan medical journal
2025

Expanding the clinical spectrum: A case report of the first Jordanian presentation of KID syndrome with neurological and skeletal anomalies beyond the classical triad.

Medicine
2026

Macular and optic nerve hypoplasia in chromosome 2p partial trisomy.

Ophthalmic genetics
2025

Visual Impairment and Ocular Findings in Children With Developmental Delay Attending a Child Development Unit Clinic at a Tertiary Hospital.

Cureus
2026

The Developmental Landscape of Children With Uveal Coloboma and Its Relationship With Clinical Phenotype and Genetics.

American journal of ophthalmology
2026

Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.

American journal of medical genetics. Part A
2025

[Clinical and genetic characteristics of 6 cases of congenital dyskeratosis in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Sudden Bilateral Vision Loss in A Young Patient with Systemic Autoimmune Disease and A Normal Brain MRI, which Responded to Steroid Treatment.

European journal of case reports in internal medicine
2026

Unraveling the relationship between childhood dry eye symptoms and sleep patterns.

Jornal de pediatria
2025

Optic nerve hypoplasia/dysplasia in Coffin-Siris syndrome: a case series.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Expanding Clinical and Genetic Landscape of SATB2-Associated Syndrome.

Genes
2025

Burden of ophthalmologic disorders in obstructive sleep apnea.

Respiratory medicine
2025

The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050.

The Lancet. Public health
2025

Understanding cognitive features of cervical dystonia: application of the cerebellar cognitive affective syndrome scale (CCAS-S).

Journal of neural transmission (Vienna, Austria : 1996)
2025

Outcomes of Maintenance Immunotherapy in a Cohort of Patients With Susac Syndrome: A 2-Center Large Case Series.

Neurology. Clinical practice
2025

Clinical and molecular findings of KMT2D-related Kabuki syndrome: A series of 13 patients with 3 novel variants.

European journal of medical genetics
2025

Ganaxolone in Epilepsy: Insights into a Neurosteroid-Based Therapy.

Epilepsy research
2025

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Radiology
2025

Adult genomic medicine: lessons from a multisite study of 2700 patients.

Genome medicine
2025

Autonomic dysfunction symptoms in Sjögren's Disease: A missed dimension linked to disease burden and work disability.

Seminars in arthritis and rheumatism
2025

Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study.

Toxins
2025

Case Report: A case of traumatic subgaleal hematoma with delayed massive exophthalmos.

Frontiers in surgery
2025

Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov.

Journal of multidisciplinary healthcare
2025

Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies.

medRxiv : the preprint server for health sciences
2025

Case Report: Observation of early-onset high myopia with fundus tessellation changes in Coffin-Siris syndrome 9 (CSS9) and literature review.

Frontiers in pediatrics
2025

Chronic Early-Life Obesity Linked to Childhood Impulsivity Predicts Long-Term Psychosis Trajectory Through Dose-Dependent Cerebellar Dysmaturation in 22q11.2 Deletion Syndrome.

Biological psychiatry. Cognitive neuroscience and neuroimaging
2025

Structural insights into the substrate uptake and inhibition of the human creatine transporter (hCRT).

Proceedings of the National Academy of Sciences of the United States of America
2025

Autoimmune thyroid disease and pituitary adenoma in a female patient with 18p deletion syndrome: a case report and review of the literature.

BMC endocrine disorders
2025

New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025.

Expert review of neurotherapeutics
2025

Multiple problems: a case of Cohen syndrome VPS13B mutation causing bilateral spherical lenses combined with retinitis pigmentosa.

BMC ophthalmology
2026

Chronic Ocular Sequelae of Stevens-Johnson Syndrome: Recent Advances in Understanding of Patho-Physiology and Management.

Seminars in ophthalmology
2026

Cortical Visual Impairment Across a Range of Neurodevelopmental Disorders: Clinical Characterization, Diagnostic Tool Evaluation, and Association with Developmental Outcomes.

Journal of child neurology
2025

Prevalence and Potential Risk Factors of Ocular Disorders Among Institutionalised Adults With Intellectual Disabilities-A City-Wide Survey in Taipei City.

Journal of intellectual disability research : JIDR
2025

Cerebral/Cortical visual impairment (CVI) in Down syndrome: a case series.

Frontiers in human neuroscience
2025

Analysis of the Body Mass Index of Latino Patients With Bardet-Biedl Syndrome.

Cureus
2025

Complex strabismus in a patient with KBG syndrome with 16q24.3 microdeletion.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Poretti-Boltshauser Syndrome: A Potential Pathognomonic "Wolfjaw" Pattern of Retinal Perfusion.

Ophthalmic surgery, lasers & imaging retina
2025

Ocular Manifestations in Congenital Insensitivity to Pain with Anhidrosis: A Window into a Rare Syndrome.

Vision (Basel, Switzerland)
2025

Systematic phenotype and genotype characterization of Moebius syndrome.

Genetics in medicine open
2025

A novel NR2F1-associated microdeletion underlying Bosch-Boonstra-Schaaf optic atrophy syndrome.

Ophthalmic genetics
2025

Blepharospasm management in Schwartz-Jampel syndrome: A systematic review.

European journal of ophthalmology
2025

Comprehensive analysis of CNOT3-related neurodevelopmental disorders: phenotypic and genotypic characterization.

European journal of human genetics : EJHG
2025

Foveal hypoplasia in Myhre syndrome: a novel association.

Ophthalmic genetics
2025

Treating Glaucoma in Intellectually Disabled Patients: Novel Criteria for Choosing Surgical Candidates.

Journal of ophthalmology
2025

The feasibility of using eye-tracking technology for cognitive screening in Down syndrome with dementia: A cross-sectional case series.

Alzheimer's & dementia : the journal of the Alzheimer's Association
2025

CHARGE Syndrome in a Six-Month-Old Male Infant: A Case Report.

Cureus
2025

Resolving the Diagnostic Odyssey in Inherited Retinal Dystrophies Through Long-Read Genome Sequencing.

American journal of medical genetics. Part A
2025

Variable expressivity of a transmitted pathogenic KAT6B variant.

European journal of medical genetics
2025

Novel KMT2D pathogenic variant causing Kabuki Syndrome with associated macular abnormalities and retinopathy of prematurity.

Ophthalmic genetics
2025

KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome.

Human molecular genetics
2025

Typical presentation of autosomal recessive oculocutaneous albinism in two siblings.

GMS ophthalmology cases
2025

Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions.

Epilepsy & behavior : E&B
2025

DYRK1A syndrome presenting with a familial exudative vitreoretinopathy (FEVR)-like retinovascular phenotype.

Ophthalmic genetics
2026

Understanding speech and language in KIF1A-associated neurological disorder.

European journal of human genetics : EJHG
2025

French protocol for diagnosis and management of type 1 interferonopathies.

La Revue de medecine interne
2026

A Novel GATAD2B Frameshift Variant Causes GATAD2B-Associated Neurodevelopmental Disorder with Camptodactyly.

Molecular syndromology
2025

Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC.

BMC pediatrics
2025

Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome can Lead to Long-Term Neurological, Neuropsychological, and Cognitive Sequelae Associated with Cerebellar Atrophy.

Cerebellum (London, England)
2025

DHX16-Associated Neuromuscular Oculoauditory Syndrome: A Novel Case.

American journal of medical genetics. Part A
2025

Clinical manifestations of dual-gene variants involving ABCA4 in retinal dystrophies.

BMC ophthalmology
2025

Healthcare needs, care use and health status outcomes in adults with Bardet-Biedl syndrome: a cross-sectional study in Norway.

BMJ open
2025

Clinical profile and treatment outcomes in acute retinal necrosis in a South Indian patient population.

Indian journal of ophthalmology
2025

Bi-allelic variants in BRF2 are associated with perinatal death and craniofacial anomalies.

Genome medicine
2025

Diagnostic Utility of Next-Generation Sequencing-based CNV Analysis in Eleven Patients with Peters-Plus Syndrome: A Single-Center Experience.

Journal of clinical research in pediatric endocrinology
2025

Charles Bonnet syndrome among visually impaired military veterans: findings from a UK screening and survey study.

BMJ open ophthalmology
2025

Clinical Presentation and Co-Morbidities in Bardet-Biedel Syndrome: Case Series from a Single Centre.

Indian journal of endocrinology and metabolism
2025

Optic atrophy in Lamb-Shaffer syndrome: two case presentations with ophthalmic imaging studies.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Recognising the neurological burden of onchocerciasis: the need to include onchocerciasis-associated epilepsy in onchocerciasis global health metrics.

Infectious diseases of poverty
2025

Diagnostic Utility of Trio-Exome Sequencing for Children With Neurodevelopmental Disorders.

JAMA network open
2025

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study.

Epilepsia
2025

Case report: ocular manifestations of NFIX-associated Malan syndrome.

Ophthalmic genetics
2025

Atypical Ophthalmological Manifestations of Claes-Jensen Syndrome Without Intellectual Disability: A Case Report.

Journal of pediatric ophthalmology and strabismus
2025

Methylphenidate for the cognitive and neurobehavioural sequelae of traumatic brain injury in adults: a systematic review and meta-analysis.

Frontiers in neurology
2025

The Intriguing Blindness of Maria Theresia von Paradis and the Instructive Potential of Medical Biography.

Cureus
2025

[Clinical features of CHARGE syndrome in children].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

Management of anophthalmia, microphthalmia and coloboma in the newborn, shared care between neonatologist and ophthalmologist: a literature review.

Italian journal of pediatrics
2025

Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.

The Journal of investigative dermatology
2025

Identification of a novel single nucleotide deletion in the NHS causing Nance-Horan syndrome.

BMC ophthalmology
2025

C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis.

bioRxiv : the preprint server for biology
2025

Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021.

HIV medicine
2025

CDK13-Related Disorder: Novel Insights From A Series of 27 Cases and Recommendations for Clinical Management.

Clinical genetics
2025

International Expert Opinion on Standard of Care for Patients With Schinzel-Giedion Syndrome: A Modified Delphi Study.

American journal of medical genetics. Part A
2025

Strabismus in Genetic Syndromes: A Review.

Clinical & experimental ophthalmology
2025

Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival.

Fluids and barriers of the CNS
2025

Torpedo maculopathy in a patient with DeSanto-Shinawi syndrome.

European journal of ophthalmology
2025

Poretti-Boltshauser Syndrome: A Report of Two Cases From Bahrain With a Novel Mutation and Literature Review.

Cureus
2025

Phenotypic variability in two siblings with Poretti-Boltshauser syndrome.

Global medical genetics
2025

Novel De Novo RALA Missense Variants Expand the Genotype Spectrum of Hiatt-Neu-Cooper Neurodevelopmental Syndrome.

Molecular genetics & genomic medicine
2025

Co-existence of strabismus and Down syndrome in relation to visual impairment in institutionalised adults with intellectual disabilities: Implications for vision care.

Journal of intellectual & developmental disability
2025

Genotype-Phenotype Correlations of Nance-Horan Syndrome in Male and Female Carriers of a Novel Variant.

Genes
2025

The Phenotypic and Genotypic Spectrum of BRPF1-Related Disorder: 29 New Patients and Literature Review.

Clinical genetics
2025

Multidisciplinary, multicenter consensus for the care of patients affected with Sturge-Weber syndrome.

Orphanet journal of rare diseases
2025

DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.

American journal of human genetics
2024

Comparative Pacing Profile and Chronometric Performance in Elite Swimmers with Intellectual Impairments and Able-Bodied Athletes.

Life (Basel, Switzerland)
2025

Systemic Diseases in Patients with Congenital Aniridia: A Report from the Homburg Registry for Congenital Aniridia.

Ophthalmology and therapy
2024

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan.

Research and reports in tropical medicine
2025

Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case-control study.

Epilepsia
2025

RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study.

Neurology(R) neuroimmunology & neuroinflammation
2025

Comprehensive Clinical and Genetic Characterization of Kabuki Syndrome: A Case Series Study.

Journal of child neurology
2024

ARID1B-related disorder in 87 adults: Natural history and self-sustainability.

Genetics in medicine open
2025

Global trends and regional differences in the burden of HIV/AIDS attributed to intimate partner violence among females in 204 countries and territories, 1999-2019: An analysis of the global burden of disease study.

Psychological trauma : theory, research, practice and policy
2025

Assessment of Affordances in the Home Environment and Neurodevelopment of Children With Congenital Zika Syndrome.

Child: care, health and development
2024

Ocular findings in Baraitser-Winter syndrome with a de novo mutation in the ACTG1 gene: a case report.

BMC ophthalmology
2025

Surgical Treatment of Strabismus in Children With Developmental Delay: A Review of the Literature and Results of Personal Experience.

Journal of pediatric ophthalmology and strabismus
2024

The Relationship Between Hand Abnormalities and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.

Journal of clinical medicine
2024

The DESSH Clinic: A New Multidisciplinary Clinic to Address the Complex Needs of Individuals with a Rare Genetic Disorder.

Missouri medicine
2024

HLA-B*51:01 in Iranian patients with Behcet uveitis syndrome.

Reumatologia clinica
2024

Homozygosity for a hypomorphic mutation in frizzled class receptor 5 causes syndromic ocular coloboma with microcornea in humans.

Human genetics
2024

PHARC syndrome: an overview.

Orphanet journal of rare diseases
2025

A coloaded liposome in situ gel as a novel therapeutic strategy to treat cerebral ischemia reperfusion injury.

Brain research
2023

A Clinical Study on Severity of Dry Eye in Individuals with Pterygium at a Tertiary Hospital in South Kerala.

Middle East African journal of ophthalmology
2025

Understanding Data and Opportunities Focused on Value: A Single-Center Experience in Headache Care.

Neurology. Clinical practice
2024

Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

High-Velocity Low-Amplitude Techniques for the Management of Discogenic Lumbosacral Radicular Syndrome: A Systematic Review.

Journal of manipulative and physiological therapeutics
2024

Second Case of Gonadal Mosaicism and a Novel Nonsense NR2F1 Gene Variant as the Cause of Bosch-Boonstra-Schaaf Optic Atrophy Syndrome.

Clinical genetics
2024

Care of children with congenital rubella syndrome (CRS) in Indonesia.

Journal of infection in developing countries
2025

Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

A novel large multi-gene deletion in syndromic choroideremia.

Ophthalmic genetics
2025

Cochlear implantation in syndromic patients: difficulties and lessons learnt.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2025

PRETERM FAMILIAL EXUDATIVE VITREORETINOPATHY: A NOVEL NONSENSE LRP5 MUTATION.

Retinal cases & brief reports
2024

Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR)- the new lacunae: a case report.

BMC ophthalmology
2024

HSCT for stiff person syndrome and myasthenia gravis.

Handbook of clinical neurology
2024

Exome sequencing confirms the clinical diagnosis of both joubert syndrome and klinefelter syndrome with keratoconus in a han Chinese family.

Frontiers in genetics
2024

SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X-Linked Intellectual Disability.

Annals of neurology
2024

Associations Between Obstructive Sleep Apnea Syndrome, Dry Eye Disease, and CPAP Usage Among Taiwanese Patients: A Retrospective Analysis.

Nature and science of sleep
2024

Long COVID Brain Fog Treatment: Findings from a Pilot Randomized Controlled Trial of Constraint-Induced Cognitive Therapy.

medRxiv : the preprint server for health sciences
2024

Lateral Rectus Disabling and Simultaneous Modified Nishida Procedure for Exotropic Duane Retraction Syndrome.

Journal of binocular vision and ocular motility
2024

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome.

American journal of medical genetics. Part C, Seminars in medical genetics
2024

Ophthalmic manifestations of NAA10-related and NAA15-related neurodevelopmental syndromes: Analysis of cortical visual impairment and refractive errors.

American journal of medical genetics. Part A
2024

Exploring the pathological mechanisms underlying Cohen syndrome.

Frontiers in neuroscience
2024

GPC4 truncating variant associated with Keipert syndrome and lacrimal punctal agenesis.

American journal of medical genetics. Part A
2024

De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity.

Brain : a journal of neurology
2024

Natural history of adults with KBG syndrome: A physician-reported experience.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Variant-specific pathophysiological mechanisms of AFF3 differently influence transcriptome profiles.

Genome medicine
2024

LZTFL1, a rare cause of Bardet-Biedl syndrome: A new patient with severe short stature and moderate intellectual disability, more than casual associations?

American journal of medical genetics. Part A
2024

De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.

BMC medical genomics
2024

Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016-2023).

American journal of medical genetics. Part A
2024

The Pressure of Headache at the United Kingdom CSF Disorders Day 2023.

Neuro-ophthalmology (Aeolus Press)
2024

Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.

Multiple sclerosis (Houndmills, Basingstoke, England)
2024

An Ultra-Rare Mixed Phenotype with Combined AP-4 and ERF Mutations: The First Report in a Pediatric Patient and a Literature Review.

Genes
2024

Management of an older Marshall-Smith syndrome patient: a review of literature of MSS and craniosynostosis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Predicting the conversion from clinically isolated syndrome to multiple sclerosis: An explainable machine learning approach.

Multiple sclerosis and related disorders
2024

Report of a Novel Homozygous Intragenic DCC Duplication and a Review of Literature of Developmental Split-Brain Syndrome aka Horizontal Gaze Palsy with Progressive Scoliosis-2 with Impaired Intellectual Development Syndrome.

Molecular syndromology
2024

Ocular Ischemic Syndrome and the Role of Carotid Artery Revascularization.

Annals of vascular surgery
2024

Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.

Current issues in molecular biology
2024

Exploring the support needs of Australian parents of young children with Usher syndrome: a qualitative thematic analysis.

Orphanet journal of rare diseases
2024

Immune Checkpoint Inhibitor-Associated Kelch-Like Protein-11 IgG Brainstem Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation
2024

Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.

Journal of medical genetics
2024

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.

The EPMA journal
2024

De novo variants in DENND5B cause a neurodevelopmental disorder.

American journal of human genetics
2024

Brain and spine malformations and neurodevelopmental disorders in a cohort of children with CAKUT.

Pediatric nephrology (Berlin, Germany)
2024

Novel Insights from Clinical Practice: Xia-Gibbs Syndrome with Pes Cavus, Conjunctival Melanosis, and Eye Asymmetry due to a de novo AHDC1 Gene Variant - A Case Report and a Brief Review of the Literature.

Molecular syndromology
2024

Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study.

European journal of human genetics : EJHG
2024

Ophthalmic Manifestations of NAA10-Related and NAA15-Related Neurodevelopmental Syndrome: Analysis of Cortical Visual Impairment and Refractive Errors.

medRxiv : the preprint server for health sciences
2024

Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations.

Stem cell research
2024

Beneficial Impact of Eicosapentaenoic Acid on the Adverse Effects Induced by Palmitate and Hyperglycemia on Healthy Rat Chondrocyte.

International journal of molecular sciences
2024

Biallelic loss-of-function variants of SLC12A9 cause lysosome dysfunction and a syndromic neurodevelopmental disorder.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.

Brain communications
2024

Expanding the phenotype of UPF3B-related disorder: Case reports and literature review.

American journal of medical genetics. Part A
2023

Respiratory involvement and sleep-related disorders in CMT1A: case report and review of the literature.

Frontiers in neurology
2024

Unilateral progressive anterior iris adhesions in Mowat-Wilson syndrome: a new ocular finding.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2024

Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome.

Brain : a journal of neurology
2024

A Homozygous NDUFS6 Variant Associated with Neuropathy and Optic Atrophy.

Journal of neuromuscular diseases
2024

Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.

Brain : a journal of neurology
2024

Variants in the WDR44 WD40-repeat domain cause a spectrum of ciliopathy by impairing ciliogenesis initiation.

Nature communications
2024

A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3.

American journal of human genetics
2024

Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events.

Neurology. Clinical practice
2023

Calciphylaxis, beware the ophthalmic mimic: A case series.

Clinical nephrology. Case studies
2024

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Ocular manifestations in Koolen-de Vries syndrome: an international study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2023

Expanding Genotype/Phenotype Correlation in 2p11.2-p12 Microdeletion Syndrome.

Genes
2023

Multicentric Carpo-Tarsal Osteolysis Syndrome (MCTO) and "Function Profile": a rehabilitative approach.

Orphanet journal of rare diseases
2023

Global Burden of Cardiovascular Diseases and Risks, 1990-2022.

Journal of the American College of Cardiology
2023

Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.

Brain : a journal of neurology
2023

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

The Cochrane database of systematic reviews
2023

Facial and ocular manifestations of male patients affected by the HUWE1-related intellectual developmental disorder.

International journal of molecular epidemiology and genetics
2023

Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years.

Brain & spine
2024

Iatrogenic affectation of ocular motility by immune checkpoint inhibitors.

Archivos de la Sociedad Espanola de Oftalmologia

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41860019mais citado
  2. CTNNB1-related disorders: clinical and radiological contributions from a French cohort.
    Frontiers in neurology· 2026· PMID 41789168mais citado
  3. International Clinical Evidence-based Guideline for Kleefstra Syndrome.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41578867mais citado
  4. Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.
    Pediatric neurology· 2026· PMID 41539009mais citado
  5. De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.
    American journal of human genetics· 2026· PMID 41468891mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:698090(Orphanet)
  2. MONDO:0015022(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome

ORPHA:698090 · MONDO:0015022
OMIM
617333
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades